Table 5 Total number of treatment initiations during the post-DAA period (n = 14,896)

From: Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection

Variable HCV (n = 14,467) % HCV/HIV (n = 429) % Total %
Untreated 9639 66.6 288 67.1 9927 66.6
Dual therapy 6 0.0 1 0.2 7 0.0
Triple therapy 179 1.2 8 1.9 187 1.3
All-oral therapy 4643 32.1 132 30.8 4775 32.1